It may be possible to utilize NFC as a biomarker ofvasculitis and/or vascular leak in IBD, which may help to guide initial anti-TNF dosing untiltherapeutic drug monitoring can occur, warranting future study. Here, TNF is linked to inflammatory bowel disease.